Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma

Meaghan L Douglas1, Michelle M Richardson, David L Nicol

  • 1Southern Clinical Division, School of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Cancer
|May 13, 2004
PubMed
Abstract

Insights

The endothelin axis shows distinct expression patterns in clear cell (ccRCC) and papillary renal cell carcinoma (PRCC). This suggests different treatment approaches are needed for these renal cell carcinoma subtypes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The endothelin signaling pathway is implicated in various cancers.
  • Gene expression of the endothelin axis in renal cell carcinoma (RCC) subtypes remains underexplored.

Purpose of the Study:

  • To investigate the expression profiles of key endothelin axis genes in clear cell RCC (ccRCC) and papillary RCC (PRCC).
  • To determine if differential gene expression correlates with known clinicopathological features of RCC subtypes.

Main Methods:

  • Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was used to analyze gene expression.
  • Tissue specimens from 35 RCC patients (22 ccRCC, 13 PRCC) were analyzed.
  • Expression of preproendothelins (PPET-1, PPET-2, PPET-3), endothelin receptors (ET(A), ET(B)), and endothelin-converting enzymes (ECE-1, ECE-2) was quantified.

Main Results:

  • PPET-1 was upregulated in ccRCC and downregulated in PRCC.
  • ET(A) was significantly downregulated in PRCC.
  • ECE-1 was ubiquitously expressed, with higher levels in normal kidney tissue adjacent to PRCC.

Conclusions:

  • Differential expression of the endothelin axis in ccRCC and PRCC correlates with tumor vascularity.
  • Elevated endothelin axis activity in ccRCC and impaired activity in PRCC were suggested.
  • Findings support distinct therapeutic strategies for ccRCC and PRCC.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...